Indeed, we found that treatment of TNBC cells with a pan-AKT inhibitor MK2206 effectively decreased phosphorylation of S1P1 T236, inhibited tumor cell migration in vitro, and suppressed tumor cell dissemination in zebrafish xenografts. Here, AKT1 is linked to neoplasm.